Anti-Cancer Agents in Medicinal Chemistry

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back Subscribe
Research Article

Chrysin Exhibits Selective Antiproliferative and Antimigratory Activities in a Wide Range of Human-derived Cervical Cancer Cell Lines

Author(s): Analine Rosa Barquez de Assis Carvalho, Gabrielle Marconi Zago Ferreira Damke, Lyvia Eloiza de Freitas Meirelles, Raquel Pantarotto Souza, Bianca Altrao Ratti, Edilson Damke, Marcos Luciano Bruschi, Marcia Edilaine Lopes Consolaro*orcid of author and Vania Ramos Sela da Silva

Volume 25, Issue 17, 2025

Published on: 21 March, 2025

Page: [1311 - 1322] Pages: 12

DOI: 10.2174/0118715206366318250312052617

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Background: In the past few years, the antiproliferative activities of chrysin (5,7-dihydroxyflavone) have garnered significant attention in anticancer drug discovery due to its promising ability to suppress cancer cell proliferation. However, studies on its effects on cervical cancer are limited and have primarily focused on HeLa cells.

Objective: In order to better understand its therapeutic potential for cervical cancer, we assessed the antiproliferative and anti-migratory effects of chrysin in a wide range of human-derived cell lines comprising C33A (human papillomavirus/HPV-negative), HeLa (HPV 18-positive), SiHa (HPV 16-positive), and CaSKi (HPV 16 and 18- positive), in comparison to a human epithelial cell line derived from spontaneously immortalized cell, HaCaT.

Methods: Cell viability was determined using the MTT assay, while the clonogenic assay evaluated long-term cytotoxicity. Morphological alterations were observed via light microscopy, and cell death was assessed using Annexin V FITC/propidium iodide (PI) staining. Total reactive oxygen species (ROS) levels were measured by fluorescence microscopy, the mitochondrial transmembrane potential was assessed using TMRE, and lipid peroxidation was analyzed using DPPP. Additionally, wound healing migration and cell invasion assays were conducted.

Results: Chrysin selectively inhibited cell proliferation and induced apoptosis in every cervical cancer cell line assessed while exerting minimal effects on HaCaT cells. Additionally, it triggered mitochondrial redox imbalance and significantly suppressed both migration and invasion of cervical cancer cells.

Conclusion: Based on these results, chrysin appears to be a promising candidate as an anticancer agent for both HPV-associated and HPV-independent cervical cancers, emphasizing the necessity for further exploration in subsequent studies.

Keywords: Cervical cancer, treatment, chrysin, antiproliferative, antimigratory, HaCaT cells.

Graphical Abstract

[1]
Singh, D.; Vignat, J.; Lorenzoni, V.; Eslahi, M.; Ginsburg, O.; Lauby-Secretan, B.; Arbyn, M.; Basu, P.; Bray, F.; Vaccarella, S. Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO Global Cervical cancer elimination initiative. Lancet Glob. Health, 2023, 11(2), e197-e206.
[http://dx.doi.org/10.1016/S2214-109X(22)00501-0] [PMID: 36528031]
[2]
Brianti, P.; De Flammineis, E.; Mercuri, S.R. Review of HPV-related diseases and cancers. New Microbiol., 2017, 40(2), 80-85.
[PMID: 28368072]
[3]
Lorusso, D.; Petrelli, F.; Coinu, A.; Raspagliesi, F.; Barni, S.; Raspagliesi, F. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol. Oncol., 2014, 133(1), 117-123.
[http://dx.doi.org/10.1016/j.ygyno.2014.01.042] [PMID: 24486604]
[4]
Barra, F.; Lorusso, D.; Maggiore, U.L.R.; Ditto, A.; Bogani, G.; Raspagliesi, F.; Ferrero, S. Investigational drugs for the treatment of cervical cancer. Expert Opin. Investig. Drugs, 2017, 26(4), 389-402.
[http://dx.doi.org/10.1080/13543784.2017.1302427] [PMID: 28274154]
[5]
Vistad, I.; Fosså, S.D.; Dahl, A.A. A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecol. Oncol., 2006, 102(3), 563-572.
[http://dx.doi.org/10.1016/j.ygyno.2006.03.050] [PMID: 16716379]
[6]
Mishra, N.; Singh, N.; Sachdeva, M.; Ghatage, P. Sexual dysfunction in cervical cancer survivors: A scoping review. Women's Health Reports, 2021, 2(1), 594-607.
[http://dx.doi.org/10.1089/whr.2021.0035] [PMID: 35141708]
[7]
Fu, Z.Z.; Li, K.; Peng, Y.; Zheng, Y.; Cao, L.Y.; Zhang, Y.J.; Sun, Y.M. Efficacy and toxicity of different concurrent chemoradiotherapy regimens in the treatment of advanced cervical cancer. Medicine (Baltimore), 2017, 96(2), e5853.
[http://dx.doi.org/10.1097/MD.0000000000005853] [PMID: 28079819]
[8]
Kinghorn, A.D.; De Blanco, E.J.C.; Lucas, D.M.; Rakotondraibe, H.L.; Orjala, J.; Soejarto, D.D.; Oberlies, N.H.; Pearce, C.J.; Wani, M.C.; Stockwell, B.R.; Burdette, J.; Swanson, S.M.; Fuchs, J.R.; Phelps, M.A.; Xu, L.; Zhang, X.; Shen, Y.Y. Discovery of anticancer agents of diverse natural origin. Anticancer Res., 2016, 36(11), 5623-5638.
[http://dx.doi.org/10.21873/anticanres.11146] [PMID: 27793884]
[9]
de Freitas Meirelles, L.E.; de Assis Carvalho, A.R.B.; Ferreira Damke, G.M.Z.; Souza, R.P.; Damke, E.; de Souza Bonfim-Mendonça, P.; de Oliveira Dembogurski, D.S.; da Silva, D.B.; Consolaro, M.E.L.; da Silva, V.R.S. Antitumoral potential of Artepillin C, a compound derived from Brazilian propolis, against breast cancer cell lines. Anticancer. Agents Med. Chem., 2024, 24(2), 117-124.
[http://dx.doi.org/10.2174/0118715206270534231103074433] [PMID: 37957873]
[10]
Souza, R.P.; Bonfim-Mendonça, P.S.; Gimenes, F.; Ratti, B.A.; Kaplum, V.; Bruschi, M.L.; Nakamura, C.V.; Silva, S.O.; Maria-Engler, S.S.; Consolaro, M.E.L. Oxidative stress triggered by apigenin induces apoptosis in a comprehensive panel of human cervical cancer-derived cell lines. Oxid. Med. Cell. Longev., 2017, 2017(1), 1512745.
[http://dx.doi.org/10.1155/2017/1512745] [PMID: 28191273]
[11]
Kasala, E.R.; Bodduluru, L.N.; Madana, R.M. v, A.K.; Gogoi, R.; Barua, C.C. Chemopreventive and therapeutic potential of chrysin in cancer: Mechanistic perspectives. Toxicol. Lett., 2015, 233(2), 214-225.
[http://dx.doi.org/10.1016/j.toxlet.2015.01.008] [PMID: 25596314]
[12]
Farkhondeh, T.; Samarghandian, S.; Bafandeh, F. The cardiovascular protective effects of chrysin: A narrative review on experimental research. Cardiovasc. Hematol. Agents Med. Chem., 2019, 17(1), 17-27.
[http://dx.doi.org/10.2174/1871525717666190114145137] [PMID: 30648526]
[13]
Ryu, S.; Lim, W.; Bazer, F.W.; Song, G. Chrysin induces death of prostate cancer cells by inducing ROS and ER stress. J. Cell. Physiol., 2017, 232(12), 3786-3797.
[http://dx.doi.org/10.1002/jcp.25861] [PMID: 28213961]
[14]
Woo, K.J.; Jeong, Y.J.; Park, J.W.; Kwon, T.K. Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem. Biophys. Res. Commun., 2004, 325(4), 1215-1222.
[http://dx.doi.org/10.1016/j.bbrc.2004.09.225] [PMID: 15555556]
[15]
Lim, W.; Ryu, S.; Bazer, F.W.; Kim, S.M.; Song, G. Chrysin attenuates progression of ovarian cancer cells by regulating signaling cascades and mitochondrial dysfunction. J. Cell. Physiol., 2018, 233(4), 3129-3140.
[http://dx.doi.org/10.1002/jcp.26150] [PMID: 28816359]
[16]
Zhang, Q.; Zhao, X.H.; Wang, Z.J. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol. In vitro, 2009, 23(5), 797-807.
[http://dx.doi.org/10.1016/j.tiv.2009.04.007] [PMID: 19397994]
[17]
Kasala, E.R.; Bodduluru, L.N.; Barua, C.C.; Gogoi, R. Chrysin and its emerging role in cancer drug resistance. Chem. Biol. Interact., 2015, 236, 7-8.
[http://dx.doi.org/10.1016/j.cbi.2015.04.017] [PMID: 25912556]
[18]
Laishram, S.; Moirangthem, D.S.; Borah, J.C.; Pal, B.C.; Suman, P.; Gupta, S.K.; Kalita, M.C.; Talukdar, N.C. Chrysin rich Scutellaria discolor Colebr. induces cervical cancer cell death via the induction of cell cycle arrest and caspase-dependent apoptosis. Life Sci., 2015, 143, 105-113.
[http://dx.doi.org/10.1016/j.lfs.2015.10.035] [PMID: 26541229]
[19]
Tang, Q.; Ji, F.; Guo, J.; Wang, J.; Li, Y.; Bao, Y. Directional modification of chrysin for exerting apoptosis and enhancing significantly anti-cancer effects of 10-hydroxy camptothecin. Biomed. Pharmacother., 2016, 82, 693-703.
[http://dx.doi.org/10.1016/j.biopha.2016.06.008] [PMID: 27470413]
[20]
Zhang, T.; Chen, X.; Qu, L.; Wu, J.; Cui, R.; Zhao, Y. Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg. Med. Chem., 2004, 12(23), 6097-6105.
[http://dx.doi.org/10.1016/j.bmc.2004.09.013] [PMID: 15519155]
[21]
Raina, R.; Afroze, N.; Sundaram, M.K.; Haque, S.; Bajbouj, K.; Hamad, M.; Hussain, A. Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways. Eur. Rev. Med. Pharmacol. Sci., 2021, 25(5), 2206-2220.
[PMID: 33755959]
[22]
Leon, I.E.; Di Virgilio, A.L.; Porro, V.; Muglia, C.I.; Naso, L.G.; Williams, P.A.M.; Bollati-Fogolin, M.; Etcheverry, S.B. Antitumor properties of a vanadyl(iv) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: The role of oxidative stress and apoptosis. Dalton Trans., 2013, 42(33), 11868-11880.
[http://dx.doi.org/10.1039/c3dt50524c] [PMID: 23760674]
[23]
Di Meo, S.; Reed, T.T.; Venditti, P.; Victor, V.M. Role of ROS and RNS sources in physiological and pathological conditions. Oxid. Med. Cell. Longev., 2016, 2016, 1245049.
[24]
Twentyman, P.R.; Luscombe, M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer, 1987, 56, 279-285.
[25]
Franken, N.A.P.; Rodermond, H.M.; Stap, J.; Haveman, J.; van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc., 2006, 1(5), 2315-2319.
[http://dx.doi.org/10.1038/nprot.2006.339] [PMID: 17406473]
[26]
Iqbal, B.; Ghildiyal, A.; Sahabjada, S.; Singh, S.; Arshad, M.; Mahdi, A.A.; Tiwari, S. Antiproliferative and apoptotic effect of curcumin and TRAIL (TNF related apoptosis inducing ligand) in chronic myeloid leukaemic cells. J. Clin. Diagn. Res., 2016, 10(4), XC01-XC05.
[http://dx.doi.org/10.7860/JCDR/2016/18507.7579] [PMID: 27190933]
[27]
Shukla, A.K.; Patra, S.; Dubey, V.K. Iridoid glucosides from Nyctanthes arbortristis result in increased reactive oxygen species and cellular redox homeostasis imbalance in Leishmania parasite. Eur. J. Med. Chem., 2012, 54, 49-58.
[http://dx.doi.org/10.1016/j.ejmech.2012.04.034] [PMID: 22608855]
[28]
Xu, J.; Hao, Z.; Gou, X.; Tian, W.; Jin, Y.; Cui, S.; Guo, J.; Sun, Y.; Wang, Y.; Xu, Z. Imaging of reactive oxygen species burst from mitochondria using laser scanning confocal microscopy. Microsc. Res. Tech., 2013, 76(6), 612-617.
[http://dx.doi.org/10.1002/jemt.22207] [PMID: 23580478]
[29]
Okimoto, Y.; Watanabe, A.; Niki, E.; Yamashita, T.; Noguchi, N. A novel fluorescent probe diphenyl‐1‐pyrenylphosphine to follow lipid peroxidation in cell membranes. FEBS Lett., 2000, 474(2-3), 137-140.
[http://dx.doi.org/10.1016/S0014-5793(00)01587-8] [PMID: 10838073]
[30]
Liang, C.C.; Park, A.Y.; Guan, J.L. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc., 2007, 2(2), 329-333.
[http://dx.doi.org/10.1038/nprot.2007.30] [PMID: 17406593]
[31]
Tomin, K.; Goldfarb, R.H.; Albertsson, P. In vitro assessment of human natural killer cell migration and invasion. Methods Mol. Biol., 2016, 1441, 65-74.
[http://dx.doi.org/10.1007/978-1-4939-3684-7_6] [PMID: 27177657]
[32]
Patel, R.V.; Mistry, B.; Syed, R.; Rathi, A.K.; Lee, Y.J.; Sung, J.S.; Shinf, H.S.; Keum, Y.S. Chrysin-piperazine conjugates as antioxidant and anticancer agents. Eur. J. Pharm. Sci., 2016, 88, 166-177.
[http://dx.doi.org/10.1016/j.ejps.2016.02.011] [PMID: 26924226]
[33]
Mistry, B.M.; Patel, R.V.; Keum, Y.S.; Kim, D.H. Chrysin–benzothiazole conjugates as antioxidant and anticancer agents. Bioorg. Med. Chem. Lett., 2015, 25(23), 5561-5565.
[http://dx.doi.org/10.1016/j.bmcl.2015.10.052] [PMID: 26514745]
[34]
Zhang, Q.; Ma, S.; Liu, B.; Liu, J.; Zhu, R.; Li, M. Chrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells. Exp. Ther. Med., 2016, 12(1), 469-474.
[http://dx.doi.org/10.3892/etm.2016.3282] [PMID: 27347080]
[35]
Sies, H. Strategies of antioxidant defense. Eur. J. Biochem., 1993, 215(2), 213-219.
[http://dx.doi.org/10.1111/j.1432-1033.1993.tb18025.x] [PMID: 7688300]
[36]
Acharya, A.; Das, I.; Chandhok, D.; Saha, T. Redox regulation in cancer: A double-edged sword with therapeutic potential. Oxid. Med. Cell. Longev., 2010, 3(1), 23-34.
[http://dx.doi.org/10.4161/oxim.3.1.10095] [PMID: 20716925]
[37]
Salimi, A.; Roudkenar, M.H.; Seydi, E.; Sadeghi, L.; Mohseni, A.; Pirahmadi, N.; Pourahmad, J. Chrysin as an anti-cancer agent exerts selective toxicity by directly inhibiting mitochondrial complex II and V in CLL B-lymphocytes. Cancer Invest., 2017, 35(3), 174-186.
[http://dx.doi.org/10.1080/07357907.2016.1276187] [PMID: 28301251]
[38]
Park, W.; Park, S.; Lim, W.; Song, G. Chrysin disrupts intracellular homeostasis through mitochondria-mediated cell death in human choriocarcinoma cells. Biochem. Biophys. Res. Commun., 2018, 503(4), 3155-3161.
[http://dx.doi.org/10.1016/j.bbrc.2018.08.109] [PMID: 30139515]
[39]
Dongre, A.; Weinberg, R.A. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol., 2019, 20(2), 69-84.
[http://dx.doi.org/10.1038/s41580-018-0080-4] [PMID: 30459476]
[40]
Puisieux, A.; Brabletz, T.; Caramel, J. Oncogenic roles of EMT-inducing transcription factors. Nat. Cell Biol., 2014, 16(6), 488-494.
[http://dx.doi.org/10.1038/ncb2976] [PMID: 24875735]
[41]
Prangsaengtong, O.; Athikomkulchai, S.; Xu, J.; Koizumi, K.; Inujima, A.; Shibahara, N.; Shimada, Y.; Tadtong, S.; Awale, S. Chrysin inhibits lymphangiogenesis in vitro. Biol. Pharm. Bull., 2016, 39(4), 466-472.
[http://dx.doi.org/10.1248/bpb.b15-00543] [PMID: 27040620]
[42]
Yang, B.; Huang, J.; Xiang, T.; Yin, X.; Luo, X.; Huang, J.; Luo, F.; Li, H.; Li, H.; Ren, G. Chrysin inhibits metastatic potential of human triple‐negative breast cancer cells by modulating matrix metalloproteinase‐10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway. J. Appl. Toxicol., 2014, 34(1), 105-112.
[http://dx.doi.org/10.1002/jat.2941] [PMID: 24122885]
[43]
Yufei, Z.; Yuqi, W.; Binyue, H.; Lingchen, T.; Xi, C.; Hoffelt, D.; Fuliang, H. Chrysin inhibits melanoma tumor metastasis via interfering with the FOXM1/β-Catenin signaling. J. Agric. Food Chem., 2020, 68(35), 9358-9367.
[http://dx.doi.org/10.1021/acs.jafc.0c03123] [PMID: 32797754]
[44]
Raina, R.; Almutary, A.G.; Bagabir, S.A.; Afroze, N.; Fagoonee, S.; Haque, S.; Hussain, A. Chrysin modulates aberrant epigenetic variations and hampers migratory behavior of human cervical (HeLa) cells. Front. Genet., 2022, 12, 768130.
[http://dx.doi.org/10.3389/fgene.2021.768130] [PMID: 35096000]
[45]
Dong, W.; Chen, A.; Chao, X.; Li, X.; Cui, Y.; Xu, C.; Cao, J.; Ning, Y. Chrysin inhibits proinflammatory factor-induced EMT phenotype and cancer stem cell-like features in HeLa Cells by blocking the NF-κB/Twist axis. Cell. Physiol. Biochem., 2019, 52(5), 1236-1250.
[http://dx.doi.org/10.33594/000000084] [PMID: 31001962]

Rights & Permissions Print Cite